KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 101 filers reported holding KARUNA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 8.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,355,415 | -47.8% | 43,500 | -33.1% | 0.96% | -31.6% |
| Q2 2023 | $14,095,250 | +83.6% | 65,000 | +53.8% | 1.41% | +24.4% |
| Q1 2023 | $7,678,831 | -20.4% | 42,275 | -13.9% | 1.13% | -18.2% |
| Q4 2022 | $9,644,417 | -52.9% | 49,081 | -46.1% | 1.39% | -20.1% |
| Q3 2022 | $20,469,000 | +205.3% | 91,000 | +71.7% | 1.74% | +130.2% |
| Q2 2022 | $6,705,000 | -26.6% | 53,000 | -26.4% | 0.75% | -2.0% |
| Q1 2022 | $9,129,000 | -7.1% | 72,000 | -4.0% | 0.77% | +11.6% |
| Q4 2021 | $9,825,000 | +642.6% | 75,000 | +581.8% | 0.69% | +499.1% |
| Q1 2021 | $1,323,000 | -79.7% | 11,000 | -82.8% | 0.12% | -77.4% |
| Q4 2020 | $6,502,000 | +14.4% | 64,000 | -12.9% | 0.51% | +9.5% |
| Q3 2020 | $5,683,000 | -32.0% | 73,500 | -2.0% | 0.46% | -56.9% |
| Q2 2020 | $8,359,000 | +29.0% | 75,000 | -16.7% | 1.08% | -13.0% |
| Q1 2020 | $6,480,000 | +17.8% | 90,000 | +23.3% | 1.24% | +16.9% |
| Q4 2019 | $5,500,000 | – | 73,000 | – | 1.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 797,008 | $134,766,083 | 53.75% |
| Nan Fung Group Holdings Ltd | 225,688 | $38,161,584 | 30.90% |
| Sofinnova Investments, Inc. | 1,381,149 | $233,538,484 | 14.73% |
| First Light Asset Management, LLC | 303,137 | $51,257,435 | 4.87% |
| Altium Capital Management LP | 34,000 | $5,749,060 | 3.00% |
| DAFNA Capital Management LLC | 52,873 | $8,940,296 | 2.78% |
| Logos Global Management LP | 115,000 | $19,445,350 | 2.59% |
| GENERAL ATLANTIC, L.P. | 986,710 | $166,842,794 | 2.58% |
| MPM BioImpact LLC | 53,210 | $8,997,279 | 2.40% |
| Rock Springs Capital Management LP | 505,433 | $85,463,666 | 2.29% |